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Herpes simplex virus type 2 (HSV-2) is the causative agent of genital herpes. Matsuzawa et 
al have demonstrated that, in a mouse model, HSV-2 pathology is influenced by the time 
infection occurs. Increased expression of the HSV-2 receptor Nectin-1 under the control of 
CLOCK coincided with an increase in viral titer suggesting that HSV-2 infection is regulated 
by the host circadian clock 
 
Human simplex virus type 2 (HSV-2) is predominantly a sexually transmitted infection and 
causes genital herpes through contact with open sores, fluids, or genital surfaces. Genital 
herpes can be asymptomatic, or alternatively present as one or more painful blisters or ulcers. 
Other symptoms may also include fever, muscular aches, and swollen lymph nodes. After an 
initial HSV-2 infection, symptoms may reoccur with approximately 5% of HSV-2 carriers 
having outbreaks once every 2 to 12 months over the duration of their lifetime. 
Approximately 417 million people are infected with the virus globally with rising infection 
rates reported in adolescents resulting in a huge medical and public health problem (WHO, 
2017). In rare cases, neonatal herpes can be contracted by exposure to the virus in the genital 
tract during delivery resulting in neurological damage or death. In addition, the incidence of 
coinfection with HIV is increased in HSV-2-infected individuals by threefold, and people 
infected with both viruses are more likely to infect others with HIV-1 (WHO, 2017).   
 
Infection with HSV-2 is incurable and lasts for the life time of the patient.  Antiviral drugs 
such as acyclovir or valacyclovir are effective against HSV-2 infections, reducing the 
severity and duration of the symptoms, but they do not prevent recurrences unless used daily. 
In addition, these antiviral drugs have little impact on the spread of HSV-2 infection with 10 
to 20 million per year continuing to acquire new infections. Research is underway to produce 
more effective methods to control HSV-2 infections such as vaccines of topical microbicides, 
but to date none are readily available for public use (Johnston et al., 2011; Nikolic and 
Piguet, 2010).   
 Matsuzawa et al. (2017) demonstrate that the expression of the HSV-2 receptor Nectin-1 in 
epithelial skin cells fluctuates with the host cell circadian (molecular) clock. Variable 
expression over time of Nectin-1 results in an enhanced uptake of HSV-2 during the “active 
phase” in a murine model, which further results in increased viral titer, cytokine expression, 
and HSV-2 pathology.   
 
Studies have to date linked numerous molecular processes within cells to the coordinated 
oscillations of the circadian clock (24-hour cycle), and this connection has become an ever 
increasing field of interest in disease regulation. The body’s internal clock is located in the 
hypothalamic suprachiasmatic nuclei. From here, neural and humoral signals regulate output 
pathways that control internal temperature, hormone regulation, metabolism, and cell cycle. 
On a molecular level, the circadian clock controls an independent transcription translation 
feedback loop including a negative feedback loop involving the genes Clock, Bmal1, Period1 
(Per1), Per2, and cryptochrome1 (Cry1) and Cry2. The 24-hour cycle starts with 
CLOCK/NPAS2 binding to BMAL1 and activating the transcription of Per and Cry that 
heterodimerize and feedback to CLOCK: BMAL1 complex resulting in a block to further 
transcription (see Figure 1). In turn, the PER-CRY complex is degraded and CLOCK: 
BMAL1 can activate a new cycle. Hundreds of genes, approximately 10-20% of all genes, 
show circadian rhythm in their expression. Although these genes display a rhythmic cycle, 
they are not directly involved in the circadian mechanics and are therefore considered to be 
clock-controlled genes. These can encode a variety of proteins, including cytokines, 
chemokines, or receptors.  Circadian cycles connected to and influencing molecular clocks 
can therefore contribute to variation of expression over a 24-hour cycle and potentially result 
in variation to disease susceptibility within the host (reviewed in Takahashi et al 2008).  
 
Research on the relationship between pathogens and the host’s circadian clock reveals new 
insights in pathogen-host interactions. Plasmodia have been previously reported to 
synchronize their replication cycle with the host’s circadian rhythm to ensure a successful 
infection (O’Donnell et al 2011). Similarly, viruses may have also evolved to take advantage 
of the host’s circadian clock, for example, hepatitis C virus has been shown to modulate 
clock gene expression with Per2 being found to inhibit viral replication (Benegiamo et al 
2013). Influenza A virus infection appears to modulate clock gene expression resulting in 
increased lung inflammation of the host (Sundar et al 2015). In addition, it has been reported 
that viral replication of wild-type HSV-1 in mice was 10-fold higher during the resting phase 
as opposed to their active phase. It was also shown that Bmal1 -/-mice, deficient in several 
circadian rhythms, had equal levels of viral replication independent of the time of infection, 
suggesting a relationship between viral infection and the circadian clock. The involvement of 
the host immune response was ruled out by showing that viral replication was still influenced 
by time in a cell model devoid of an active immune response. Viral replication was found to 
be linked to Bmal1 expression levels, and the viral protein ICP0 of HSV-1 was found to 
enhance clock gene Bmal1, suggesting that other viruses may also have evolved to 
specifically target the circadian machinery to their advantage (Edgar et al 2016).   
 
Matsuzawa et al now demonstrate that HSV-2 pathology, viral titer, and innate immune 
responses varied depending on the time at which the mice were infected, with mice showing 
more severe infection at the active phase (ZT18/night) in comparison to the rest phase 
(ZT6/day). Similar observations were made in RAG-2-deficient mice, suggesting that 
acquired immunity did not influence the differential infection levels observed, which agrees 
with previous studies. The authors went on to demonstrate that expression of the HSV-2 
receptor Nectin1 (Pvrl1) is upregulated during the active phase in correlation to increased 
viral pathology and titer observed. Expression levels of Pvrl1 were found to fluctuate over 
time, and the authors demonstrated that Nectin-1 expression was under the direct regulation 
of the Clock gene and therefore the host circadian clock (see Figure 1). Furthermore, and 
adding some clinical relevance to their findings, they also show that a larger dose of acyclovir 
is necessary to treat HSV-2 acquired in the active phase compared with the lower dose 
required to control infection acquired during the rest phase (Matsuzawa et al 2017).  
 
In light of these studies, it would be of interest to see if changes in circadian gene expression 
and resulting effects on  the host cells can also influence viral transmission to naıve hosts. For 
example, could fluctuating expression levels of viral genes influence the rate of transmission 
between hosts in a time dependent manner? However, as with all complex pathways, it 
should also be kept in mind that Clock genes control multiple host cellular pathways 
influencing the immune response and cell metabolism to name a few. In addition, research in 
this field will no doubt be of importance for novel therapeutic strategies looking into how the 
circadian clock may influence the administration of drugs, such as time of treatment.  Finally, 
identification of circadian genes involved in viral propagation could be used as targets for 
antiviral therapies and help develop other novel strategies for disease prevention.  
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 Figure 1. 
 
 
 
 
Pvrl1 expression is under the control of the circadian CLOCK in murine keratinocytes 
resulting in increased HSV-2 pathology at the active phase.   
The host circadian clock controls a transcription-translation feedback loop involving the genes 
CLOCK/NPAS2, Bmal1, Period1 (Per1), Per2 and Cryptochrome1 (Cry1) and Cry2. CLOCK: 
BMAL1 activate transcription of the Per1/2 and Cry1/2 genes. The PER and CRY proteins go on 
to heterodimerise resulting in translocation to the nucleus where they inhibit their own 
transcription by interacting with CLOCK:BMAL1 over a 24 hour period. Wild-type mice were 
intradermally infected with HSV-2 at ZT6 ‘rest phase’ (ZT6) or ‘active phase’ (ZT18). CLOCK 
was found to bind to an E-box-like region present in the promoter region of the gene Prvl1 causing 
an increase in expression levels of the HSV-2 receptor Nectin-1 in the active phase which 
correlated to an observed increase in pathology and viral titre in comparison to mice infected at 
rest phase (ZT6). 
